Terms: = Colorectal cancer AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1
296 results:
1. High expression of runx1 in colorectal cancer subtype accelerates malignancy by inhibiting HMGCR.
Chang Z; Liu B; He H; Li X; Shi H
Pharmacol Res; 2024 Aug; 206():107293. PubMed ID: 38971271
[TBL] [Abstract] [Full Text] [Related]
2. runx1 regulates MCM2/CDC20 to promote COAD progression modified by deubiquitination of USP31.
Tian W; Zhao J; Zhang X; Li P; Li X; Hong Y; Li S
Sci Rep; 2024 Jun; 14(1):13906. PubMed ID: 38886545
[TBL] [Abstract] [Full Text] [Related]
3. Diagnostic performance of Node Reporting and Data System (Node-RADS) for assessing mesorectal lymph node in rectal cancer by CT.
Niu Y; Wen L; Yang Y; Zhang Y; Fu Y; Lu Q; Wang Y; Yu X; Yu X
BMC Cancer; 2024 Jun; 24(1):716. PubMed ID: 38862951
[TBL] [Abstract] [Full Text] [Related]
4. Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer.
Drew DA; Kim AE; Lin Y; Qu C; Morrison J; Lewinger JP; Kawaguchi E; Wang J; Fu Y; Zemlianskaia N; Díez-Obrero V; Bien SA; Dimou N; Albanes D; Baurley JW; Wu AH; Buchanan DD; Potter JD; Prentice RL; Harlid S; Arndt V; Barry EL; Berndt SI; Bouras E; Brenner H; Budiarto A; Burnett-Hartman A; Campbell PT; Carreras-Torres R; Casey G; Chang-Claude J; Conti DV; Devall MAM; Figueiredo JC; Gruber SB; Gsur A; Gunter MJ; Harrison TA; Hidaka A; Hoffmeister M; Huyghe JR; Jenkins MA; Jordahl KM; Kundaje A; Le Marchand L; Li L; Lynch BM; Murphy N; Nassir R; Newcomb PA; Newton CC; Obón-Santacana M; Ogino S; Ose J; Pai RK; Palmer JR; Papadimitriou N; Pardamean B; Pellatt AJ; Peoples AR; Platz EA; Rennert G; Ruiz-Narvaez E; Sakoda LC; Scacheri PC; Schmit SL; Schoen RE; Stern MC; Su YR; Thomas DC; Tian Y; Tsilidis KK; Ulrich CM; Um CY; van Duijnhoven FJB; Van Guelpen B; White E; Hsu L; Moreno V; Peters U; Chan AT; Gauderman WJ
Sci Adv; 2024 May; 10(22):eadk3121. PubMed ID: 38809988
[TBL] [Abstract] [Full Text] [Related]
5. ctDNA as a predictor of outcome after curative resection for locally advanced rectal cancer: systematic review and meta-analysis.
Nassar A; Aly NE; Jin Z; Aly EH
Colorectal Dis; 2024 Jul; 26(7):1346-1358. PubMed ID: 38802990
[TBL] [Abstract] [Full Text] [Related]
6. runx1-induced upregulation of PTGS2 enhances cell growth, migration and invasion in colorectal cancer cells.
Zheng W; Guo Y; Kahar A; Bai J; Zhu Q; Huang X; Li Y; Xu B; Jia X; Wu G; Zhang C; Zhu Y
Sci Rep; 2024 May; 14(1):11670. PubMed ID: 38778047
[TBL] [Abstract] [Full Text] [Related]
7. Predictors of high-intensity care at the end of life among older adults with solid tumors: A population-based study.
Baird CE; Wulff-Burchfield E; Egan PC; Hugar LA; Vyas A; Trikalinos NA; Liu MA; Bélanger E; Olszewski AJ; Bantis LE; Panagiotou OA
J Geriatr Oncol; 2024 Jun; 15(5):101774. PubMed ID: 38676975
[TBL] [Abstract] [Full Text] [Related]
8. Outcomes of 10 years of PSA screening for prostate cancer in Norwegian men with Lynch syndrome.
Grindedal EM; Zucknick M; Stormorken A; Rønne E; Tandstad NM; Isaacs WB; Axcrona K; Mæhle L
Prostate; 2024 Jul; 84(10):945-953. PubMed ID: 38629217
[TBL] [Abstract] [Full Text] [Related]
9. Real-world data evaluating Guy's rapid diagnostic clinic as an alternate pathway for patients with FIT levels below 10.
Monroy-Iglesias MJ; Martin S; Cargaleiro C; Jones G; Steward L; Murtagh C; Bruno F; Millwaters J; Schizas A; Watson H; Haire A; Haire K; Moss CL; Russell B; Srirajaskanthan R; Van Hemelrijck M; Dolly S
BMJ Open; 2024 Apr; 14(4):e080285. PubMed ID: 38626962
[TBL] [Abstract] [Full Text] [Related]
10. miR-575/RIPK4 axis modulates cell cycle progression and proliferation by inactivating the Wnt/β-catenin signaling pathway through inhibiting runx1 in colon cancer.
Wang Q; Lu W; Lu L; Wu R; Wu D
Mol Cell Biochem; 2024 Jul; 479(7):1747-1766. PubMed ID: 38480605
[TBL] [Abstract] [Full Text] [Related]
11. Prediction of 30-day, 90-day, and 1-year mortality after colorectal cancer surgery using a data-driven approach.
Bräuner KB; Tsouchnika A; Mashkoor M; Williams R; Rosen AW; Hartwig MFS; Bulut M; Dohrn N; Rijnbeek P; Gögenur I
Int J Colorectal Dis; 2024 Feb; 39(1):31. PubMed ID: 38421482
[TBL] [Abstract] [Full Text] [Related]
12. Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database.
Karapetis CS; Liu H; Sorich MJ; Pederson LD; Van Cutsem E; Maughan T; Douillard JY; O'Callaghan CJ; Jonker D; Bokemeyer C; Sobrero A; Cremolini C; Chibaudel B; Zalcberg J; Adams R; Buyse M; Peeters M; Yoshino T; de Gramont A; Shi Q
Br J Cancer; 2024 May; 130(8):1269-1278. PubMed ID: 38402342
[TBL] [Abstract] [Full Text] [Related]
13. Circulating miRNAs and lncRNAs serve as biomarkers for early colorectal cancer diagnosis.
Lotfi E; Kholghi A; Golab F; Mohammadi A; Barati M
Pathol Res Pract; 2024 Mar; 255():155187. PubMed ID: 38377721
[TBL] [Abstract] [Full Text] [Related]
14. Comparative analysis of silver-nanoparticles and whey-encapsulated particles from olive leaf water extracts: Characteristics and biological activity.
Mansour HMM; Shehata MG; Abdo EM; Sharaf MM; Hafez EE; Galal Darwish AM
PLoS One; 2023; 18(12):e0296032. PubMed ID: 38109310
[TBL] [Abstract] [Full Text] [Related]
15. Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.
Flecchia C; Auclin E; Alouani E; Mercier M; Hollebecque A; Turpin A; Mazard T; Pernot S; Dutherage M; Cohen R; Borg C; Hautefeuille V; Sclafani F; Ben-Abdelghani M; Aparicio T; De La Fouchardière C; Herve C; Perkins G; Heinrich K; Kunzmann V; Gallois C; Guimbaud R; Tougeron D; Taieb J
Br J Cancer; 2024 Feb; 130(3):442-449. PubMed ID: 38102227
[TBL] [Abstract] [Full Text] [Related]
16. Adjuvant chemotherapy decision-making in stage II colon adenocarcinoma associated with patients' age and high-risk factors.
Zheng P; Ye C; Liu H; Gao X; Huang H
Int J Colorectal Dis; 2023 Dec; 39(1):3. PubMed ID: 38091096
[TBL] [Abstract] [Full Text] [Related]
17. Self-supervised representation learning using feature pyramid siamese networks for colorectal polyp detection.
Gan T; Jin Z; Yu L; Liang X; Zhang H; Ye X
Sci Rep; 2023 Dec; 13(1):21655. PubMed ID: 38066207
[TBL] [Abstract] [Full Text] [Related]
18. Adjuvant chemotherapy in patients with clinically node-negative but pathologically node-positive rectal cancer in the Netherlands: A retrospective analysis.
Kwakman JJM; Bond MJG; Demichelis RM; Koopman M; Hompes R; Elferink MAG; Punt CJA
Eur J Cancer; 2024 Jan; 197():113466. PubMed ID: 38061213
[TBL] [Abstract] [Full Text] [Related]
19. Surgical Outcomes in Total Neoadjuvant Therapy for Rectal cancer Versus Standard Long-course Chemoradiation: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Lin W; Li C; Clement EA; Brown CJ; Raval MJ; Karimuddin AA; Ghuman A; Phang PT
Ann Surg; 2024 Apr; 279(4):620-630. PubMed ID: 38009646
[TBL] [Abstract] [Full Text] [Related]
20. Development of a joint prediction model based on both the radiomics and clinical factors for preoperative prediction of circumferential resection margin in middle-low rectal cancer using T2WI images.
Ju Y; Zheng L; Qi W; Tian G; Lu Y
Med Phys; 2024 Apr; 51(4):2563-2577. PubMed ID: 37987563
[TBL] [Abstract] [Full Text] [Related]
[Next]
